{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:56:40Z","timestamp":1648583800320},"reference-count":29,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1185\/030079906x96362","type":"journal-article","created":{"date-parts":[[2006,2,17]],"date-time":"2006-02-17T21:19:19Z","timestamp":1140211159000},"page":"631-639","source":"Crossref","is-referenced-by-count":3,"title":["Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment"],"prefix":"10.1185","volume":"22","author":[{"given":"Kurt","family":"Bestehorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"V\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Benecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Karmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Wegscheider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2006,2,16]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"issue":"2","key":"CIT0002","first-page":"152","volume":"105","author":"Fedder DO","year":"2002","journal-title":"New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy \u2013 projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X38187"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1159\/000075707"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.8.2274"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04257-4"},{"key":"CIT0008","volume":"30","author":"Jukema JW","year":"2004","journal-title":"Presentation (hotline session) at the Annual Meeting of the European Society of Cardiology, Munich"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00436-X"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0801-9"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2307\/2335942"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh104"},{"key":"CIT0016","first-page":"995","volume":"357","author":"Euroaspire I","year":"2001","journal-title":"Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.107997"},{"issue":"15","key":"CIT0019","first-page":"1177","volume":"23","author":"Fox KAA","year":"2002","journal-title":"Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2923.2002.01140.x"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010011"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.1.1.11"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.4065\/80.5.587"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X28872"},{"issue":"5","key":"CIT0025","first-page":"467","volume":"44","author":"Kosoglou T","year":"2005","journal-title":"Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet"},{"issue":"7404","key":"CIT0026","first-page":"1423","volume":"326","author":"Law MR","year":"2003","journal-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Brit Med J"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00737.x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420130016003"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7404.1427"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-005-0066-7"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04235-5"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.2002.1050"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X96362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T03:47:57Z","timestamp":1481600877000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X96362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,16]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,2,17]]},"published-print":{"date-parts":[[2006,4]]}},"alternative-id":["10.1185\/030079906X96362"],"URL":"https:\/\/doi.org\/10.1185\/030079906x96362","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,16]]}}}